ET1
Product Description
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
Categories
Specifications
BrightGene Bio-Medical Technology Co.,Ltd.
-
Country/Region:China
-
On CPHI since:2015
More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)
-
Product Ascomycin
• Status: DMF No.: 029433 • Usage: Oncology -
Product Pneumocandin B0
• Status: DMF Ready • Usage: For Caspofungin -
Product Echinocandin B0
• Status: DMF Ready • Usage: For Anidulafungin -
Product POB
• Status: DMF Ready • Usage: For Posaconazole -
Product POA
• Status: DMF Ready • Usage: For Posaconazole -
Product MFA
• Status: DMF No.:030028 • Usage: For Micafungin -
Product FSC
• Status: DMF No.: 028552 • Usage: For Fondaparinux Sodium -
Product Dydrogesterone
• Status: Pilot • Patent Expiration: Off-patent • Usage: Progestogens -
Product Oritavancin
• Status: Pre-validation • Patent Expiration: Off-patent • Usage: Anti-infection -
Product Pimecrolimus
• Status: DMF No.: 030090 • Patent Expiration: Off-patent • Usage: Immunosuppressant -
Product Everolimus（without BHT）
• Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology -
Product Midostaurin
• Status: Validated • Patent Expiration: Off-patent • Usage: Oncology